PT-2024-14984 · Mi̇A-Med · Mi̇A-Med

Published 2024-02-08 · Updated 2026-05-20 · CVE-2023-6515

Positive Technologies (AI Summary)

CVSS v3.1

8.8

High

Base vector

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Name of the Vulnerable Software and Affected Versions MİA-MED versions prior to 1.0.7

Description The issue is related to an Authorization Bypass Through User-Controlled Key vulnerability, allowing authentication abuse. This vulnerability enables potential attackers to bypass authentication mechanisms, which could lead to unauthorized access.

Recommendations For versions prior to 1.0.7, update to version 1.0.7 or later to resolve the issue. As a temporary workaround, consider restricting access to sensitive areas of the system to minimize the risk of exploitation.

Fix

IDOR

Weakness Enumeration

CWE-639

Related Identifiers

CVE-2023-6515

Affected Products

Mi̇A-Med

References · 7

• https://nvd.nist.gov/vuln/detail/CVE-2023-6515 · Security Note
• https://osv.dev/vulnerability/CVE-2023-6515 · Vendor Advisory
• https://siberguvenlik.gov.tr/guvenlik-bildirimleri/detay/tr-24-0087 · Note
• https://usom.gov.tr/bildirim/tr-24-0087 · Note
• https://t.me/cveNotify/164192 · Telegram Post
• https://t.me/cvenotify/74173 · Telegram Post
• https://twitter.com/cracbot/status/1756906188644794589 · Twitter Post